Cannabidiol (CBD) is gaining popularity as a therapeutic agent for a wide variety of illnesses, and even those who oppose medical marijuana are beginning to see the benefits of this non-psychoactive cannabinoid. CBD has been recognized for its potential to treat epilepsy and reduce inflammation, among many other benefits, and it is now available in various products like oils, topicals, and gummies/edibles. Some products isolate CBD from other cannabinoids that exist in the marijuana plant, while others are considered full spectrum, and keep other cannabinoids like CBN, CBL, THCV, and CBCVA, for their own unique benefits. Some even contain small amounts of THC.
Previous beliefs held that CBD isolates contained higher concentration of CBD and were more potent than full spectrum CBD, but this was debunked in a 2015 study from the Lautenberg Center for General Tumor Immunology in Jerusalem. Researchers from the study administered increasing doses of full spectrum CBD to mice and found it offered greater levels of relief than CBD isolates of the same dose. Some researchers belief this is because CBD buffers against the psychoactive effects of cannabinoids so that patients can reap the full benefits of different cannabinoids without experiencing side effects.
This information has been provided by MassRoots and approved by our Chief Medical Officer.